Compare MYGN & GMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | GMTL |
|---|---|---|
| Founded | 1991 | 2021 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 369.4M |
| IPO Year | 1996 | 2024 |
| Metric | MYGN | GMTL |
|---|---|---|
| Price | $3.05 | $13.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $7.64 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 2.4M | 223.9K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $6.86 | N/A |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $2.74 | $8.60 |
| 52 Week High | $8.59 | $22.21 |
| Indicator | MYGN | GMTL |
|---|---|---|
| Relative Strength Index (RSI) | 27.39 | 56.40 |
| Support Level | $2.74 | $12.64 |
| Resistance Level | $5.52 | $17.88 |
| Average True Range (ATR) | 0.25 | 1.04 |
| MACD | -0.11 | 0.48 |
| Stochastic Oscillator | 10.94 | 84.27 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Guardian Metal Resources PLC focuses on metals exploration and development, with a focus on precious metals exploration in North America. The Company has one business segment, which is the exploration and evaluation of mineral resources in Nevada, USA. Its exploration projects comprise the Pilot Mountain Project, Tempiute Project, Golconda Summit Project, Stonewall Project, and Garfield Project, and the Group is the operator of the Golconda Summit Project.